Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1987 May;55(5):499–502. doi: 10.1038/bjc.1987.101

Response of an ocular melanoma to subconjunctival injection of 5-thio-D-glucose or cis-platin.

K A Skov, C Kumi, J Rootman, N Bussanich, M O Fellenz
PMCID: PMC2001735  PMID: 3606943

Abstract

Successful treatment of ocular tumours by chemotherapy and radiotherapy is sometimes limited by the special nature of the eye. Improvement is needed to avoid enucleation. Previous studies using locally administered antineoplastic agents have given promising results in the treatment of experimental ocular melanoma and spontaneous lymphoma. Another approach is use of radiosensitizers to improve radiotherapeutic effect. For the present study, 5-thio-D-glucose and cis-platin were chosen for evaluation in an ocular system because they exhibit antitumour activity, and interaction with radiation, particularly in hypoxia. Ocular absorption, toxicity, and pharmacokinetics after subconjunctival administration in rabbits were determined, and the effect of drug on tumours was measured using a Greene melanoma model. CHO cells were used for complimentary in vitro studies. 5-thio-D-glucose was readily absorbed into the eye (300 mg resulting in 5 mM in the aqueous) with no observable toxicity. When 5TG (300 mg) was administered at implantation, tumours were approximately half the size of controls. 5 mM 5TG is toxic to extremely hypoxic cells and gives measurable radiosensitization. Cis-platin levels as high as 0.68 microM were attained in the aqueous without local toxicity after 400 micrograms injection. This concentration causes toxicity in vitro. Cis-platin (400 mg) had a larger effect on tumour growth than 5TG given at, or one week after, implantation. Cis-platin may have potential for treatment of ocular tumours by local injection.

Full text

PDF
499

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Coughlin C. T., Grace M., O'Donnell J. F., LeMarbre P. J., Morain W. D., Geurkink N. A., McIntyre O. R. Combined modality approach in the management of locally advanced head and neck cancer. Cancer Treat Rep. 1984 Apr;68(4):591–597. [PubMed] [Google Scholar]
  2. Douple E. B., Richmond R. C. Radiosensitization of hypoxic tumor cells by cis- and trans-dichlorodiammineplatinum (II). Int J Radiat Oncol Biol Phys. 1979 Aug;5(8):1369–1372. doi: 10.1016/0360-3016(79)90672-2. [DOI] [PubMed] [Google Scholar]
  3. Draper G. J., Sanders B. M., Kingston J. E. Second primary neoplasms in patients with retinoblastoma. Br J Cancer. 1986 May;53(5):661–671. doi: 10.1038/bjc.1986.110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Greene H. S., Harvey E. K. The growth and metastasis of amelanotic melanomas in heterologous hosts. Cancer Res. 1966 Apr;26(4):706–714. [PubMed] [Google Scholar]
  5. Harwood A. R., Cummings B. J. Radiotherapy for malignant melanoma: a re-appraisal. Cancer Treat Rev. 1981 Dec;8(4):271–282. doi: 10.1016/s0305-7372(81)80011-4. [DOI] [PubMed] [Google Scholar]
  6. Moore B. A., Palcic B., Skarsgard L. D. Radiosensitizing and toxic effects on the 2-nitroimidazole Ro-07-0582 in hypoxic mammation cells. Radiat Res. 1976 Sep;67(3):459–473. [PubMed] [Google Scholar]
  7. Nagle W. A., Moss A. J., Jr, Roberts H. G., Jr, Baker M. L. Effects of 5-thio-D-glucose on cellular adenosine triphosphate levels and deoxyribonucleic acid rejoining hy hypoxic and aerobic Chinese hamster cells. Radiology. 1980 Oct;137(1 Pt 1):203–211. doi: 10.1148/radiology.137.1.7422846. [DOI] [PubMed] [Google Scholar]
  8. Nias A. H. Radiation and platinum drug interaction. Int J Radiat Biol Relat Stud Phys Chem Med. 1985 Sep;48(3):297–314. doi: 10.1080/09553008514551301. [DOI] [PubMed] [Google Scholar]
  9. Rockwell S., Schulz R. J. Failure of 5-thio-D-glucose to alter cell survival in irradiated or unirradiated EMT6 tumors. Radiat Res. 1984 Dec;100(3):527–535. [PubMed] [Google Scholar]
  10. Rootman J., Bussanich N., Gudauskas G. Combined local chemotherapy for a spontaneously occurring intraocular tumour in a cat. Can J Ophthalmol. 1983 Jun;18(4):185–187. [PubMed] [Google Scholar]
  11. Rootman J., Gudauskas G., Kumi C. Subconjunctival versus intravenous cytosine arabinoside: effect of route of administration and ocular toxicity. Invest Ophthalmol Vis Sci. 1983 Dec;24(12):1607–1611. [PubMed] [Google Scholar]
  12. Rootman J., Gudauskas G. Treatment of ocular leukemia with local chemotherapy. Cancer Treat Rep. 1985 Jan;69(1):119–122. [PubMed] [Google Scholar]
  13. Rootman J., Josephy P. D., Adomat H., Palcic B. Ocular absorption and toxicity of a radiosensitizer and its effect on hypoxic cells. Arch Ophthalmol. 1982 Mar;100(3):468–471. doi: 10.1001/archopht.1982.01030030470020. [DOI] [PubMed] [Google Scholar]
  14. Rootman J., Ostry A., Gudauskas G. Pharmacokinetics and metabolism of 5-fluorouracil following subconjunctival versus intravenous administration. Can J Ophthalmol. 1984 Jun;19(4):187–191. [PubMed] [Google Scholar]
  15. Schulz R. J., Bongiorni P. On the specific toxicity of 5-thio-D-glucose to hypoxic cells. Radiat Res. 1984 Feb;97(2):352–364. [PubMed] [Google Scholar]
  16. Schuman V. L., Levitt S. H., Song C. W. The radioprotective effect of 5-thio-D-glucose on normal tissues in vivo. Int J Radiat Oncol Biol Phys. 1982 Mar-Apr;8(3-4):589–591. doi: 10.1016/0360-3016(82)90690-3. [DOI] [PubMed] [Google Scholar]
  17. Song C. W., Clement J. J., Levitt S. H. Cytotoxic and radiosensitizing effects of 5-thio-D-glucose on hypoxic cells. Radiology. 1977 Apr;123(1):201–205. doi: 10.1148/123.1.201. [DOI] [PubMed] [Google Scholar]
  18. Song C. W., Sung J. H., Clement J. J., Levitt S. H. Cytotoxic effect of 5-thio-D-glucose on chronically hypoxic cells in multicell spheroids. Br J Cancer Suppl. 1978 Jun;3:136–140. [PMC free article] [PubMed] [Google Scholar]
  19. Tannock I. F., Guttman P., Rauth A. M. Failure of 2-deoxy-D-glucose and 5-thio-D-glucose to kill hypoxic cells of two murine tumors. Cancer Res. 1983 Mar;43(3):980–983. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES